Status:
COMPLETED
The Clinical Efficacy of Hip Protection Orthosis for the Protection of Hip Dislocation
Lead Sponsor:
Seoul National University Hospital
Collaborating Sponsors:
Korea Health Industry Development Institute
Conditions:
Cerebral Palsy
Eligibility:
All Genders
1-10 years
Phase:
NA
Brief Summary
Single Blinded, Randomized-control tiral, Multicenter clinical trial
Eligibility Criteria
Inclusion
- GMFCE level IV or V in the Cerebral palsy
- age from 1 to 10
Exclusion
- History of hip joint surgery
- Botulinum toxin injection to hip muscle past 3 months or expected in our study duration
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2021
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04033289
Start Date
August 1 2019
End Date
October 31 2021
Last Update
August 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea, 463-707